Cost of exome analysis in patients with intellectual disability: a micro-costing study in a French setting

BACKGROUND: With the development of next generation sequencing technologies in France, exome sequencing (ES) has recently emerged as an opportunity to improve the diagnosis rate of patients presenting an intellectual disability (ID). To help French policy makers determine an adequate tariff for ES,...

Descripción completa

Detalles Bibliográficos
Autores principales: Soilly, AL, Robert-Viard, C, Besse, C, Bruel, AL, Gerard, B, Boland, A, Piton, A, Duffourd, Y, Muller, J, Poë, C, Jouan, T, El Doueiri, S, Faivre, L, Bacq-Daian, D, Isidor, B, Genevieve, D, Odent, S, Philip, N, Doco-Fenzy, M, Lacombe, D, Asensio, ML, Deleuze, JF, Binquet, C, Thauvin-Robinet, C, Lejeune, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120135/
https://www.ncbi.nlm.nih.gov/pubmed/37085862
http://dx.doi.org/10.1186/s12913-023-09373-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120135/
https://www.ncbi.nlm.nih.gov/pubmed/37085862
http://dx.doi.org/10.1186/s12913-023-09373-z

Ejemplares similares